The result of DOR (serum HE4: 43 (95% CI: 23-72); urine HE4: 55 (95% CI: 15-198)) in our meta-analysis further reinforces the ability of HE4 to differentiate between benign and malignant ovarian tumors. The gene discussed is WFDC2; the disease is ovarian cancer.